The Oncology Institute, Inc.
NCM: TOILive Quote
📈 ZcoreAI Score
Our AI model analyzes The Oncology Institute, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get TOI Z-Score →About The Oncology Institute, Inc.
Healthcare
Medical Care Facilities
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
📊 Fundamental Analysis
The Oncology Institute, Inc. demonstrates a profit margin of -12.1%, which is below the sector average, suggesting competitive pressure.
The company recently reported 41.6% revenue growth, which is well above average for the Healthcare sector.
At a current price of $3.08, TOI currently sits at the 42nd percentile of its 52-week range (Range: $1.80 - $4.88).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Revenue Growth
Excellent
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$304.42M
Trailing P/E
--
Forward P/E
-19.25
Beta (5Y)
0.20
52W High
$4.88
52W Low
$1.80
Avg Volume
1.97M
Day High
Day Low